AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Hepatitis B Vaccine Response Falls Short In Youth, Those With HIV.(Brief Article)

Vaccine Weekly

| November 07, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 NOV 7 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Older adolescents may not be fully protected after being vaccinated against hepatitis B virus.

Furthermore, youth who are infected with human immunodeficiency virus (HIV) appear to be even more unprotected, according to University of Alabama - Birmingham investigators.

A new retrospective and prospective analysis of youth enrolled in the REACH (Reaching for Excellence in Adolescent Care and Health) cohort has shown that of 61 adolescents who received three doses of HBV vaccine prior to participation in the study, only 70% were protected against HBV. In youth infected with HIV who were fully vaccinated before study enrollment, the protection rate was only 41.1%, C.M. Wilson and colleagues said.

Within a year of enrolling in the study, 43 more adolescents received their third and final dose of hepatitis B vaccine. "The rates of response were similar for the HIV infected and uninfected groups (37.1% vs. 37.5%)," Wilson and coworkers noted.

Statistical analysis showed that among the 35 youngsters with HIV enrolled in the prospective portion of the study, elevated levels of certain T cells (CD8[superscript]+/CD38[superscript]+/HLA-DR[superscript]+) correlated with a lack of ...

Related articles from newspapers, magazines, journals, and more
Hepatitis B Vaccine Response Falls Short In Youth, Those With HIV.
Newspaper article from: Hepatitis Weekly November 5, 2001 700+ words
...HIV infected and high-risk HIV uninfected adolescents in the...Researchers were surprised by the poor vaccine response rates in healthy adolescents. "The poor HBV vaccine response rate in the HIV uninfected high-risk adolescents...
The Effect of Random Vaccine Response on the Vaccination Coverage Required To...
Newspaper article from: Vaccine Weekly March 1, 1999 700+ words
...Starczak, D.N. "The Effect of Random Vaccine Response on the Vaccination Coverage Required...coverage (CVC) and the effect of the vaccine response is determined entirely by the mean...problem because A and B refer to the vaccine response of the same individual. Similar results...
The Effect of Prednisone on Influenza Vaccine Response in Asthmatic Children.
Newspaper article from: Vaccine Weekly March 22, 1999 700+ words
Influenza Vaccines "The Effect of Prednisone on Influenza Vaccine Response in Asthmatic Children." M.P. Fairchok, D.P. Trementozzi, P.S. Carter, H.L. Regnery and E.R. Carter. Madigan...
deCODE Awarded $24 Million by NIH to Study Genetics of Infectious Disease and...
Press release article from: PR Newswire October 8, 2004 700+ words
...approach and resources to discover genetic factors associated with susceptibility to certain infectious diseases and with vaccine response. deCODE will be working with scientists at the University of New Mexico (UNM) to conduct functional validation of biological...
Flu Vaccine Response Boosted By Novavax Technology
Press release article from: PR Newswire December 18, 1997 700+ words
COLUMBIA, Md., Dec. 18 /PRNewswire/ -- Novavax, Inc. (Amex: NOX) said its Novasome(R) microencapsulation technology combined with recombinant Interleukin-1 beta boosted the immune response of a commercial influenza A vaccine in animal trials. The results provide new clues on possible ways to
Abatacept partially disrupts vaccine response.(Rheumatology)
Magazine article from: Internal Medicine News Walsh, Nancy October 1, 2007 700+ words
BARCELONA -- The first study to evaluate the response to pneumococcal vaccination in patients with rheumatoid arthritis receiving abatacept found that modulation of T-cell costimulation by this agent did not completely inhibit the humoral response to the vaccine, Dr. Michael Schiff reported at the
Virginia receives smallpox vaccine; Response crews to get shots first.(PAGE ONE)
Newspaper article from: The Washington Times January 29, 2003 700+ words
Byline: Matthew Cella, THE WASHINGTON TIMES The Virginia Department of Health in Richmond received 10,000 doses of smallpox vaccine from the U.S. Centers for Disease Control and Prevention yesterday to administer to those public health care workers likely to respond to a bioterrorist attack. The
Abatacept partly disrupts vaccine response.(Across Specialties)(Clinical report)
Magazine article from: Skin & Allergy News Walsh, Nancy October 1, 2007 700+ words
BARCELONA -- The first study to evaluate the response to pneumococcal vaccination in patients with rheumatoid arthritis receiving abatacept found that modulation of T-cell costimulation by this agent did not completely inhibit the humoral response to the vaccine, Dr. Michael Schiff reported at the
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA